Skip to content

CardioGenics Holdings Inc.: 10-Q/A filed 2012-04-16

What CardioGenics Holdings Inc. reported in its quarterly report amendment filed 2012-04-16 (fiscal Q1 2012): 30 published measures, 71 facts as tagged in accession 0001144204-12-021766.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-Q/A (quarterly report amendment)
Filed
2012-04-16
Fiscal period
fiscal Q1 2012
Accession
0001144204-12-021766 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CardioGenics Holdings Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-01-31833,469USD
At 2011-10-311,165,473USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-01-31600,511USD
At 2011-10-31625,037USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-01-31564,545USD
At 2011-10-31869,960USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-01-31370,493USD
At 2011-10-31669,202USD
At 2011-01-311,872,329USD
At 2010-10-311,844,752USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-11-01 to 2012-01-31-314,970USD92
1997-11-20 to 2012-01-31-41,046,144USD5186
2010-11-01 to 2011-01-31-503,156USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-11-01 to 2012-01-31-296,827USD92
1997-11-20 to 2012-01-31-6,675,051USD5186
2010-11-01 to 2011-01-31-262,323USD92

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-11-01 to 2012-01-313,892USD92
1997-11-20 to 2012-01-31223,558USD5186

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2011-11-01 to 2012-01-311,136USD92
1997-11-20 to 2012-01-3110,012USD5186

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-11-01 to 2012-01-31-6,935USD92
1997-11-20 to 2012-01-317,343,754USD5186
2010-11-01 to 2011-01-31287,874USD92

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-11-01 to 2012-01-31-4,501USD92
1997-11-20 to 2012-01-31-342,852USD5186

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-01-3181,646USD
At 2011-10-3182,308USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
1997-11-20 to 2012-01-312,508,282USD5186

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-11-01 to 2012-01-31-334,926USD92
1997-11-20 to 2012-01-31-26,590,987USD5186
2010-11-01 to 2011-01-31-461,436USD92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-01-31621,782USD
At 2011-10-31952,433USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-01-31600,511USD
At 2011-10-31622,407USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-01-313,747USD
At 2011-10-319,002USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-11-01 to 2012-01-31336,062USD92
1997-11-20 to 2012-01-3126,600,999USD5186
2010-11-01 to 2011-01-31461,436USD92

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-11-01 to 2012-01-31156,044USD92
1997-11-20 to 2012-01-313,844,015USD5186
2010-11-01 to 2011-01-31158,924USD92

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-01-3141,774,001USD
At 2011-10-3141,774,001USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2012-01-31-163,852USD
At 2011-10-31-173,407USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2012-01-31232,958USD
At 2011-10-31540,436USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2012-01-31130,041USD
At 2011-10-31130,732USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2011-11-01 to 2012-01-31-317,033USD92
1997-11-20 to 2012-01-31-41,377,729USD5186
2010-11-01 to 2011-01-31-506,570USD92

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2011-11-01 to 2012-01-31-305,415USD92

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-11-01 to 2012-01-31174,163USD92
1997-11-20 to 2012-01-317,788,640USD5186
2010-11-01 to 2011-01-31296,812USD92

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2011-11-01 to 2012-01-314,555USD92
1997-11-20 to 2012-01-31205,994USD5186
2010-11-01 to 2011-01-314,658USD92

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2011-11-01 to 2012-01-311,300USD92
1997-11-20 to 2012-01-3113,711USD5186
2010-11-01 to 2011-01-311,042USD92

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2011-11-01 to 2012-01-3117,893USD92
1997-11-20 to 2012-01-31-14,749,031USD5186
2010-11-01 to 2011-01-31-45,134USD92

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
1997-11-20 to 2012-01-315,624,169USD5186
2010-11-01 to 2011-01-31297,747USD92

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-11-01 to 2012-01-31-5,255USD92
1997-11-20 to 2012-01-313,747USD5186

Inspect the source

Entity
CardioGenics Holdings Inc. / CIK 0001089029
Captured
SEC response SHA-256
fc1d26b5dc66df3e12f4b0071eebc7f92b6a2feccc83acfb92e8a5959410b4c0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001089029.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))